InsidersTradesSigma
Follow the ADC Therapeutics SA stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €128.9m. The latest transaction was disclosed on 2 July 2026 (Attribution). Among the most active insiders: Redmile Group, LLC. All data is free.
78
Insider Decl.
n/a
Thresholds
€1m
2 ops.
Buy Volume
€17m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ADC Therapeutics SA Buy (bullish), based on 3 analysts. Average price target: US$3.33.
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
Declarations78 total
675,000 sharesCommon SharesSEC:0001628280-26-047031:0
203,700 sharesCommon SharesSEC:0001628280-26-047033:0
221,100 sharesCommon SharesSEC:0001628280-26-047034:0
213,900 sharesCommon SharesSEC:0001628280-26-047036:0
12,600 shares@ US$3.08100.0% of flowCommon SharesSEC:0001628280-26-040487:1
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
2,596 shares@ US$3.0836.8% of flowCommon SharesSEC:0001628280-26-040490:1
15,196 shares@ US$3.0838.0% of flowCommon SharesSEC:0001628280-26-040492:1
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040493:1
45,000 shares0Common SharesSEC:0001628280-26-040487:0
45,000 shares0Common SharesSEC:0001628280-26-040488:0
45,000 shares0Common SharesSEC:0001628280-26-040490:0
45,000 shares0Common SharesSEC:0001628280-26-040491:0
45,000 shares0Common SharesSEC:0001628280-26-040492:0
45,000 shares0Common SharesSEC:0001628280-26-040493:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040491:1
196,229 shares@ US$3.7523.5% of flowCommon StockSEC:0001104659-26-039359:0
188,407 shares@ US$3.7523.4% of flowCommon StockSEC:0001104659-26-039359:1
169,265 shares@ US$3.7993.0% of flowCommon StockSEC:0001104659-26-039359:2
162,517 shares@ US$3.7992.9% of flowCommon StockSEC:0001104659-26-039359:3
2,634,506 shares@ US$3.27941.1% of flowCommon StockSEC:0001104659-26-039359:4
2,529,491 shares@ US$3.27939.5% of flowCommon StockSEC:0001104659-26-039359:5
62,900 shares@ US$3.9967.0% of flowCommon SharesSEC:0001628280-26-009283:0
25 of 78 declarations
关于 ADC Therapeutics SA
ADC Therapeutics SA 是一家生物制药公司，专注于开发用于癌症治疗的靶向疗法。该公司专门从事抗体药物偶联物和创新疗法，以改善患者预后。